EQ vs OGN · rev $41.1M vs P/E 3.4, rev $6.40B
Equillium Inc (EQ) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
EQ currently screens at market cap $189.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the EQ and OGN stock pages for the full models.
Not investment advice.